Cells and tumor models

YG Yugang Guo
YX Yu-Qing Xie
MG Min Gao
YZ Yang Zhao
FF Fabien Franco
MW Mathias Wenes
IS Imran Siddiqui
AB Alessio Bevilacqua
HW Haiping Wang
HY Hanshuo Yang
BF Bing Feng
XX Xin Xie
CS Catherine M. Sabatel
BT Benjamin Tschumi
AC Amphun Chaiboonchoe
YW Yuxi Wang
WL Weimin Li
WX Weihua Xiao
WH Werner Held
PR Pedro Romero
PH Ping-Chih Ho
LT Li Tang
request Request a Protocol
ask Ask a question
Favorite

B16F10 melanoma cell, CT26 mouse colorectal cancer cell, human epidermal growth factor receptor 2 (HER2) positive SKOV3 human ovarian cancer cell (SKOV3-HER2), HEK293T and Phoenix-Eco cell were originally acquired from the American Type Culture Collection. B16-gp33, B16F10-OVA, and YUMM1.7-OVA mouse melanoma cell lines were generated as previously reported9,49. HER2 transduced MC38 mouse colon cancer cell line (MC38-HER2) and ME275 human melanoma cell line (ME275-HER2) were generated according to the previous publication50. All the mouse tumor cells and SKOV3-HER2 cells were cultured in complete Dulbecco’s modified Eagle’s medium (DMEM), a DMEM (Gibco / Thermo Fisher Scientific) medium supplemented with fetal bovine serum (FBS) (10% v/v, Gibco / Thermo Fisher Scientific) and penicillin/streptomycin (1% v/v, Gibco / Thermo Fisher Scientific). ME275-HER2 human melanoma cells were cultured in RPMI-1640 (Gibco / Thermo Fisher Scientific) medium supplemented with FBS (10% v/v, Gibco / Thermo Fisher Scientific), HEPES (pH 7.2~7.5, 1% v/v, Gibco / Thermo Fisher Scientific), penicillin/streptomycin (1% v/v, Gibco / Thermo Fisher Scientific). B16F10, YUMM1.7-OVA, B16F10-OVA, B16-gp33, or MC38-HER2 tumor cells (5 × 105 or 1 × 106 or as indicated) were implanted subcutaneously (s.c.) into the right flanks of Thy1.2+ C57BL/6 wild-type (WT) mice to establish the syngeneic tumor models. CT26 mouse colorectal cancer cells (3 × 105) were s.c. inoculated into the right flanks of BALB/c mice.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A